Purchase Order 75N93024P00784
Award Date 6/27/24
Potential Completion Date 9/30/24
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This contract was awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Codex Biosolutions Inc., a minority-owned small disadvantaged business, to identify cellular factors that impact the production of a full-length HIV-1 envelope trimer without altering its native antigenic properties. The $599,424.00 firm-fixed-price contract is funded through the Small Business Innovation Research (SBIR) program and...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $47,575.30 firm fixed price purchase order to Immudex USA, LLC for custom T-cell receptor reagents. Per the original solicitation, Immudex will provide design of relevant TCR constructs, protein expression, quality control, and final production of these reagents. The reagents will support identification and enumeration of antigen presenting...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Diagenode, LLC, a for-profit limited liability company, to provide epigenomic sequencing services and bioinformatics analysis. The one-year contract, valued at $61,310.00, does not have a set-aside designation. The services will support the National Institute of Allergy and Infectious Diseases' research on variable penetrance...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,324 firm fixed price purchase order to 10X Genomics, Inc. for unspecified products or services in support of the agency's research programs. The contract has a period of performance from September 26, 2023 through October 25, 2023 and will be performed in Pleasanton, California. This sole source award was set aside for total small businesses. No additional...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,347.40, is for DNA services including subcloning, mutagenesis, gene synthesis, and plasmid production to support NIAID's Vaccine Research Center's...
- This is a federal contract award made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The $555,600.00 contract was awarded to IDT Biologika GMBH, a German biotechnology company, for the development and manufacture of toxoid fusion proteins and master cell banks. The contract has a total ceiling value of $1,693,261.00 and is a delivery order with a...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm-fixed-price purchase order contract for $14,887.50 to Parse Biosciences, Inc., a for-profit manufacturer of biotechnology products and services. The contract, which does not have a set-aside designation, is for the delivery of reagents to support single-cell RNA and T-cell receptor (TCR) sequencing of secondary hemophagocytic...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases Division of Acquisitions awarded a $103,508.51 purchase order to Trenzyme GmbH of Bethesda, Maryland. The contract calls for the prime contractor to perform PCR-amplification and cloning of a tet-on inducible exoin-C/E3/E2/6K/E1 vector to support the agency's biomedical research efforts. Work will be conducted in Bethesda through January 18, 2010 under a fixed price...
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Genscript USA Inc. on August 23, 2023, for DNA services valued at $34,502.16. The order covers gene synthesis, VectorArk cloning, and express plasmid preparation. Performance occurs in Piscataway, New Jersey. The services support development of peptide and protein immunogens and DNA constructs for MPER-scaffolded proteins used in vaccine research against HIV, influenza, Ebola, Marburg, and other infectious...
- The National Center for Advancing Translational Sciences awarded a purchase order to Dexorgen Inc. (operating as Codex Biosolutions Inc.), a minority-owned small disadvantaged business, valued at $13,230.00 on March 11, 2020. No set-aside was used. The order, classified as a firm fixed-price purchase order, was completed on April 10, 2020. Work was performed at Westlake, Maryland. The order was placed for biotechnological research and development services within the awardee's core specialization...